James Schaub - 16 Dec 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc (RVLP)

Role: EVP and COO
Signature: /s/ Christopher Klein, as attorney-in-fact
Issuer symbol: RVLP
Transactions as of: 16 Dec 2021
Transactions value $: $100,366
Form type: 4
Filing time: 20 Dec 2021, 16:03:41 UTC
Previous filing: 08 Nov 2021
Next filing: 26 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVLP	Ordinary Shares	Purchase	$100K	+93.8K	+30.05%	$1.07	406K	16 Dec 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.08, inclusive. The Reporting Person undertakes to provide to Osmotica Pharmaceuticals plc, any security holder of Osmotica Pharmaceuticals plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.08, inclusive. The Reporting Person undertakes to provide to Osmotica Pharmaceuticals plc, any security holder of Osmotica Pharmaceuticals plc, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.